China launches first large-scale stem cell antiaging trial
A 2,000-person study at Beijing’s renowned 301 Hospital aims to determine whether stem cells can help people maintain…
No limits: NewLimit lands $435m ahead of human trials
The longevity biotech is accelerating toward the clinic after uncovering a promising age-reprogramming therapy years sooner than expected.…
Variant Bio launches AI-powered platform for drug discovery using genetic data
Jan 6 (Reuters) – Variant Bio, a private biotech firm, said on Tuesday it has launched a platform…